Wegovy pill: what to know about oral Wegovy for weight loss

If a fear of needles has kept you from taking Wegovy (semaglutide), we have good news. Oral Wegovy — aka the Wegovy pill — is officially available (and on Ro, no less!).  

The US Food and Drug Administration (FDA) approved the Wegovy pill in late December 2025, based on promising clinical trials that showed a similar weight loss to the Wegovy injection.

Read on as we break down the latest news about the Wegovy pill, including how it works for weight loss, possible side effects, and how much oral Wegovy might cost you out-of-pocket.

The Wegovy pill became available US on January 5, 2026. (And you can even get it on Ro — if appropriate, of course.) 

In late December 2025, the FDA officially approved the Wegovy pill for the following indications:

• To reduce excess body weight and maintain weight reduction long term in

  • Adults with obesity

  • Adults with overweight and at least one weight-related medical condition (e.g. high blood pressure, type 2 diabetes)

• To reduce the risk of serious cardiovascular problems (e.g. heart attack, stroke, death from heart disease) in adults with cardiovascular disease and either obesity or overweight

Upon receiving FDA approval, the Wegovy pill became the first oral GLP-1 explicitly approved for weight loss — but not the first oral GLP-1 overall. That honor belongs to Rybelsus, which is also manufactured by Novo Nordisk.

Rybelsus contains the same active ingredient as the Wegovy pill: semaglutide. It’s approved to control blood sugar levels in people with type 2 diabetes and to reduce the risk of serious cardiovascular problems in people with type 2 diabetes. 

In addition to the pill, Wegovy is also available as a weekly injection (and it has been since June 2021). Injectable Wegovy is approved for weight loss, fatty liver disease, and to lower cardiovascular risk in adults with obesity or overweight and heart disease.

It’s also worth noting that the Wegovy pill may be just the start — other oral GLP-1s may soon be FDA-approved for weight loss and diabetes. 

Novo Nordisk’s competitor, Eli Lilly, is also busy working on a GLP-1 pill called orforglipron.

• In a 40-week trial, participants with type 2 diabetes who took orforglipron daily lost 5%–8% of their body weight, or about 10–16 pounds. 

• In another trial, participants with obesity who took orforglipron lost an average of 9%–15% of their body weight after 36 weeks. 

The development of an oral Wegovy (and, frankly, orforglipron) that’s equally as or close to as effective as injectable GLP-1s is exciting. This is largely because “pills are easier to take,” says Kevin Gendreau, MD, a board-certified obesity medicine physician. 

“I’ve had many patients who dislike needles be hesitant to take these life-saving GLP-1 medications,” Dr. Gendreau says. “Pills have a broader acceptance and appeal in my opinion.” 

Indeed, surveys show that when given the option, most people prefer an oral GLP-1 over an injection. 

See if you qualify

The Wegovy pill contains the same active ingredient as injectable Wegovy, semaglutide. So, it works in the same way: by mimicking GLP-1, a naturally occurring hormone that regulates appetite and satiety (fullness). 

Here’s how semaglutide — and, thus, oral Wegovy — works: 

• It binds to GLP-1 receptors throughout your gastrointestinal (GI) tract and brain.

• It sends satiety (fullness) signals to your brain, which reduces appetite.

• It slows gastric emptying (how quickly food leaves your stomach), which makes you feel full sooner.

• It balances your blood sugar levels by boosting insulin production and limiting glucagon.

Thanks to these effects, people tend to eat fewer calories and lose weight on Wegovy. In the case of the Wegovy pill, people taking 25 mg daily experienced an average weight loss of nearly 14% (13.6%, to be exact) over a year and three months.

Of course, individual weight loss results can vary. They depend on factors such as other medications in your regimen, diet, and exercise routine. 

Both the Wegovy pill and Rybelsus, the oral form of semaglutide approved for type 2 diabetes, should be taken in the same way: 

• In the morning on an empty stomach

• At least 30 minutes before any food, water, or other medications 

“This could potentially cause problems for patients taking other medications first thing in the morning on an empty stomach, such as levothyroxine (for the treatment of hypothyroidism),” says Shannon Fitzgerald, PharmD, a pharmacist, toxicologist, and expert contributor at Drugwatch.com.  

The Wegovy pill can produce an average weight loss of 13.6% in 64 weeks (about a year and three months), according to clinical trials. So, if you weigh 250 pounds, that’s a loss of 34 pounds. 

By comparison, people taking a placebo lost only 2.2% of their starting body weight.

Other clinical trials found that a higher dose of oral Wegovy (50 mg daily) produced even more weight loss — up to 15.1% in 68 weeks. 

Another clinical trial found that 50 mg of oral Wegovy reduced people’s caloric intake by nearly 40% in 20 weeks, leading to an average weight loss of 9.8%.

At this time, however, Novo Nordisk has yet to seek approval for the 50-mg dose of oral Wegovy. This is likely due to the higher rate of gastrointestinal side effects seen with 50 mg, which affected about 80% of participants. 

The Wegovy pill can produce similar weight loss results to the Wegovy injection. But the existing research suggests the injections still work slightly better. 

• In clinical trials of oral Wegovy, people taking 25 mg daily lost an average of 13.6% of their body weight in 64 weeks. People taking 50 mg daily lost an average of 15.1% in 68 weeks.

• In clinical trials of injectable Wegovy, people taking 2.4 mg weekly lost an average of 14.9% of their body weight in 68 weeks. 

So, people may lose slightly more weight on injectable Wegovy compared to 25 mg of oral Wegovy. 

But if a 50-mg daily dose is prescribed (which will likely be an off-label dosage), people may actually lose more weight on the Wegovy pill vs. injection. 

The lower weight loss of the Wegovy pill could be due to its bioavailability (or how much of a drug’s active ingredient gets absorbed by your bloodstream), Dr. Gendreau explains.  

“Digestive breakdown in the gut might reduce effectiveness [of the Wegovy pill], requiring higher doses to reach similar efficacy as an injection,” he says. 

That may explain why the Wegovy pill that’s approved by the FDA is 25 mg while the Wegovy injection is only 2.4 mg.

Even so, the Wegovy pill seems to drive enough weight loss to be a viable alternative to GLP-1 injections, according to Dr. Gendreau. 

Current research suggests that injectable Wegovy slightly outperforms oral Wegovy — but only by a little (nearly 15% vs. 14%, respectively). 

Still, there are other injectable GLP-1s that outperform any form of semaglutide. 

Zepbound (tirzepatide) and Mounjaro (tirzepatide), for example, produce an average weight loss of 15%–20.9% in about the same time, according to a 72-week trial for obesity.

The Wegovy pill has similar side effects and risks as other semaglutide medications, mostly affecting the GI system. 

Based on phase 3 trials of the 25-mg Wegovy pill, the frequency of GI side effects was similar to what was seen in trials of Wegovy 2.4 mg weekly injections. These include:  

• Nausea

• Diarrhea

• Vomiting

• Constipation

• Stomach pain

• Headache

• Fatigue

• Upset stomach

• Dizziness

• Bloating

• Belching

• Flatulence

• Hypoglycemia (low blood sugar) in people taking certain diabetes drugs

• Stomach flu

• Heartburn

• Common cold

One possible benefit of a Wegovy pill is avoiding injection site reactions such as pain, rash, or irritation, Dr. Fitzgerald adds. However, these only affect a small number of people taking injectable Wegovy.

Without insurance, the Wegovy pill has a cash price of $149–$299 per month, depending on the dose, when prescribed and purchased on Ro. It also has a list price of $1,349.02.

Here’s a breakdown of the self-pay or cash prices for the Wegovy pill when prescribed and purchased on Ro: 

• $149 per month for the 1.5 mg dose

• $149 per month for the 4 mg dose (through April 15, 2026), then $199 per month 

• $299 per month for the 9 mg and 26 mg doses 

With insurance, the Wegovy pill can cost between $25 and $299 per month. How much you’ll end up paying for oral Wegovy depends on your insurance coverage and eligibility for the Wegovy Savings Offer from Novo Nordisk.

• If you have a commercial insurance plan that includes coverage for Wegovy (and you meet other eligibility requirements), you can pay as little as $25 for Wegovy with the manufacturer’s Wegovy Savings Offer. 

• If your plan does not include coverage for Wegovy, the Savings Offer caps your price at $149 per month for the 1.5 mg and 4 mg dosage strengths and $299 per month for the 9 mg and 25 mg dosage strengths.

The Wegovy pill is taken once a day and is available in four dosage strengths: 

• 1.5 mg

• 4 mg

• 9 mg

• 25 mg 

Similar to the injection, oral Wegovy dosing follows a titration, or step-up, schedule in which dosage strengths are gradually increased to give your body time to adjust and reduce the risk of side effects.

In practice, this may look like:

Your exact dose and timing may vary depending on how you respond to the Wegovy pill and your health and weight loss goals. So, be sure to follow your healthcare provider’s instructions and never adjust doses on your own. 

While there are a few restrictions on administering oral Wegovy, the process is simple: just three steps. 

Here’s how to take the Wegovy pill: 

1. Take one tablet of Wegovy daily on an empty stomach as soon as you wake up. 

2. Swallow the Wegovy pill whole with as little water as possible (4 ounces or less).

3. Wait at least 30 minutes before eating, drinking, or taking other oral medications. 

See if you qualify

For people who’ve avoided GLP-1 injections due to a fear of needles, oral Wegovy could be a game-changer. Now that it’s FDA-approved and available, the Wegovy pill is the first oral GLP-1 medication specifically for weight loss. Here’s what you need to know:

• The FDA approved the once-daily Wegovy pill (25 mg) on December 22, 2025. 

• As of January 5, 2026, the Wegovy pill is available in the US and costs a cash price of $149–$299 per month, depending on the dose, on Ro. It’s list price is $1,349.02.

• In clinical trials, 25 mg of the daily Wegovy pill produced an average 13.6% weight loss, which is close to the 14.9% seen with 2.4 mg weekly injections.

• Side effects of oral Wegovy in studies are similar to the mild-to-moderate gastrointestinal side effects common with the injectable version.